I’ve been with many a person who has type 1, when the person is told if they would just eat, drink, or rub this potion on their body, or if they would just think a certain way, they would no longer have type 1 diabetes. When I see or hear this, I become very angry and protective. Today, a woman who has had type 1 diabetes for almost 30 years told me she went to an alternative healer for an essential oils treatment. The “healer” told her if she would rub the cinnamon oils on her ankles it would heal her diabetes. She asked me what I thought.
Read More »Kimberly Ward Part 4, The Accu-Chek System Difference
In part 4 of this Exclusive Interview, DIC Publisher Steve Freed asks how does the Roche system differ from other products currently on the market?
Read More »Ghost Pills
When it comes to metformin, when appropriate, I recommend the extended release version. Last week my patient, female, 56 years of age, type 2 diabetes, visited. A1C was elevated, and she gained 5 pounds. She had been on metformin ER for the last 6 months and doing well. She said she recently noticed a bean-looking/pill-looking thing in her stools that seemed to be related to her metformin.
Read More »Kimberly Ward Part 3, Recruiting Healthcare Providers
In part 3 of this Exclusive Interview, Kimberly Ward explains how to get busy healthcare providers to use the information provided by the Accu-Chek system.
Read More »Kimberly Ward Part 2, Integrating Accu-Check with Apple
In part 2 of this Exclusive Interview, Kimberly Ward explains the integration of the Accu-Check system with an Apple app and how the system's features benefit patients and physicians alike.
Read More »Death Rate and Blood Glucose Management
Is extreme blood glucose control increasing or decreasing mortality rate in hospitalized patients?
Read More »HbA1c Testing Becoming a New Norm in Healthcare Setting
HbA1c testing determines diabetes and prediabetes in patients who are not yet diagnosed
Read More »HbA1c Changes Against Microvascular Complications in Type 1 Diabetes
Does HbA1c variability predict retinopathy, nephropathy?
Read More »How Will CGM’s Success Impact Conventional Glucose Monitors?
Guest Post by David Kliff, Diabetic Investor
The FDA approved Dexcom’s request for a non-adjunctive claim this week. It looks like a bad situation for conventional glucose monitors, and believe it or not is about to get worse. Here’s why.
What’s Important to Your Patient?
Male, 26 years of age, type 2 diabetes, obesity, hyperlipidemia, hypertension. Strong family history of type 2 diabetes with complications. Has been a patient since diagnosed 2 years ago. Has met with dietitian. Hasn’t made dietary changes, increased activity, or taken meds prescribed to lower his glucose. A1C 9.2% and rising every 3 months. He would also miss many of his appointments. Stated, “Nothing is going to bother me. Maybe it did my family, but that was a different time and it’s not going to happen to me. I’m going to go on enjoying my life.”
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.